Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) - Total Liabilities

Latest as of March 2026: NT$1.28 Billion TWD ≈ $40.20 Million USD

Based on the latest financial reports, Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has total liabilities worth NT$1.28 Billion TWD (≈ $40.20 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Chunghwa Chemical Synthesis & Biotech Co (1762) net asset momentum to track the company's year-over-year net asset growth rate.

Chunghwa Chemical Synthesis & Biotech Co Ltd - Total Liabilities Trend (2008–2025)

This chart illustrates how Chunghwa Chemical Synthesis & Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Chunghwa Chemical Synthesis & Biotech Co free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Chunghwa Chemical Synthesis & Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Chunghwa Chemical Synthesis & Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Samsung Pharm KO:001360	Korea	₩44.04 Billion
Advero Properties SOCIMI S.A. MC:YADV	Spain	€8.49 Million
Gopeng Bhd KLSE:2135	Malaysia	RM243.67 Million
Lee Chi Enterprises Co Ltd TW:1517	Taiwan	NT$601.02 Million
Noble Development Public Company Limited BK:NOBLE	Thailand	฿18.54 Billion
Guizhou Zhongyida Co Ltd SHG:900906	China	$908.87 Million
Nanoform Finland Plc HE:NANOFH	Finland	€12.56 Million
Iljin Diamond KO:081000	Korea	₩68.98 Billion

Liability Composition Analysis (2008–2025)

This chart breaks down Chunghwa Chemical Synthesis & Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 1762 market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.29	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chunghwa Chemical Synthesis & Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chunghwa Chemical Synthesis & Biotech Co Ltd (2008–2025)

The table below shows the annual total liabilities of Chunghwa Chemical Synthesis & Biotech Co Ltd from 2008 to 2025.

Year	Total Liabilities	Change
2025-12-31	NT$1.23 Billion ≈ $38.75 Million	-12.50%
2024-12-31	NT$1.41 Billion ≈ $44.29 Million	-22.82%
2023-12-31	NT$1.82 Billion ≈ $57.38 Million	+32.84%
2022-12-31	NT$1.37 Billion ≈ $43.20 Million	-7.76%
2021-12-31	NT$1.49 Billion ≈ $46.83 Million	+129.23%
2020-12-31	NT$648.48 Million ≈ $20.43 Million	-54.45%
2019-12-31	NT$1.42 Billion ≈ $44.85 Million	+15.05%
2018-12-31	NT$1.24 Billion ≈ $38.99 Million	-23.93%
2017-12-31	NT$1.63 Billion ≈ $51.25 Million	+70.43%
2016-12-31	NT$954.48 Million ≈ $30.07 Million	-5.20%
2015-12-31	NT$1.01 Billion ≈ $31.72 Million	-36.74%
2014-12-31	NT$1.59 Billion ≈ $50.14 Million	+19.74%
2013-12-31	NT$1.33 Billion ≈ $41.88 Million	-0.80%
2012-12-31	NT$1.34 Billion ≈ $42.21 Million	+91.80%
2011-12-31	NT$698.59 Million ≈ $22.01 Million	+1.57%
2010-12-31	NT$687.80 Million ≈ $21.67 Million	-38.48%
2009-12-31	NT$1.12 Billion ≈ $35.22 Million	-22.31%
2008-12-31	NT$1.44 Billion ≈ $45.34 Million	--

About Chunghwa Chemical Synthesis & Biotech Co Ltd

TW:1762 Taiwan Biotechnology

Market Cap

$79.00 Million

NT$2.51 Billion TWD

Market Cap Rank

#20016 Global

#1164 in Taiwan

Share Price

NT$32.60

Change (1 day)

+1.24%

52-Week Range

NT$24.30 - NT$42.30

All Time High

NT$102.50